JaeGyunMaengMD

Physician

Dr. Maeng is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of Tennessee College of Medicine at ChattanoogaResidency, Pediatrics, 2022 - 2025
East Tennessee State University James H. Quillen College of MedicineClass of 2022

PubMed

Discovery and Optimization of a Novel Series of Competitive and Central Nervous System-Penetrant Protease-Activated Receptor 4 (PAR4) Inhibitors.
Jeanette L. Bertron, Matthew T. Duvernay, Sidnee G Mitchell, Shannon T. Smith, Jae G. Maeng
ACS Chemical Neuroscience. 2021-12-02
7 citations
Repurposing of a thromboxane receptor inhibitor based on a novel role in metastasis identified by Phenome Wide Association Study
Thomas A. Werfel, Donna J. Hicks, Bushra Rahman, Wendy E. Bendeman, Matthew T. Duvernay
Molecular Cancer Therapeutics. 2020-10-08
7 citations
Identification of the minimum PAR4 inhibitor pharmacophore and optimization of a series of 2-methoxy-6-arylimidazo[2,1-b][1,3,4]thiadiazoles
Kayla J. Temple, Matthew T. Duvernay, Jae G. Maeng, Anna L. Blobaum, Shaun R. Stauffer
Bioorganic & Medicinal Chemistry Letters. 2016-11-15